伊布替尼
套细胞淋巴瘤
医学
心房颤动
内科学
淋巴瘤
心脏病学
白血病
慢性淋巴细胞白血病
作者
Hun Ju Lee,Dai Chihara,Michael L. Wang,Elie Mouhayar,Peter Y. Kim
标识
DOI:10.3109/10428194.2016.1169408
摘要
Ibrutinib is a Bruton tyrosine kinase inhibitor approved by the U.S. Food and Drug Administration for the treatment of refractory mantle cell lymphoma (MCL). It has shown promising results in MCL,[...
科研通智能强力驱动
Strongly Powered by AbleSci AI